CIMAZ, ROLANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.707
EU - Europa 11.611
AS - Asia 3.170
OC - Oceania 270
AF - Africa 174
SA - Sud America 101
Continente sconosciuto - Info sul continente non disponibili 2
Totale 39.035
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.627
RU - Federazione Russa 4.402
IE - Irlanda 1.673
PL - Polonia 1.571
SE - Svezia 1.339
IT - Italia 1.252
SG - Singapore 975
HK - Hong Kong 883
CN - Cina 598
FI - Finlandia 428
AU - Australia 269
DE - Germania 260
TR - Turchia 243
IN - India 232
GB - Regno Unito 218
UA - Ucraina 155
CI - Costa d'Avorio 123
JO - Giordania 107
BR - Brasile 92
ES - Italia 87
FR - Francia 85
CA - Canada 72
CH - Svizzera 53
VN - Vietnam 48
ID - Indonesia 39
NL - Olanda 30
BE - Belgio 17
SC - Seychelles 17
AT - Austria 16
IR - Iran 9
KR - Corea 8
EG - Egitto 7
MU - Mauritius 7
JP - Giappone 6
BG - Bulgaria 5
MA - Marocco 5
MX - Messico 5
RO - Romania 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
KZ - Kazakistan 3
LV - Lettonia 3
SA - Arabia Saudita 3
TN - Tunisia 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
BJ - Benin 2
CM - Camerun 2
ET - Etiopia 2
EU - Europa 2
LB - Libano 2
LT - Lituania 2
PE - Perù 2
AR - Argentina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
CU - Cuba 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GP - Guadalupe 1
HU - Ungheria 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SI - Slovenia 1
SN - Senegal 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 39.035
Salva come PNG Salva come JPEG
Città #
Santa Clara 4.219
Fairfield 3.160
Chandler 1.690
Dublin 1.672
Warsaw 1.568
Ashburn 1.414
Woodbridge 1.390
Cambridge 1.300
Seattle 1.262
Houston 1.117
Wilmington 1.029
Altamura 787
Singapore 737
Lawrence 719
Princeton 645
Hong Kong 474
Ann Arbor 450
Boston 386
Jacksonville 337
Beijing 279
Melbourne 262
Izmir 238
Boardman 215
Medford 214
Mumbai 189
San Diego 184
Moscow 135
New York 129
Abidjan 123
Falls Church 112
Florence 100
Buffalo 98
Norwalk 80
Barcelona 79
Shanghai 79
Toronto 55
Bern 52
Hillsboro 49
Yubileyny 45
Andover 43
Jakarta 39
Dong Ket 38
Kent 36
London 34
Los Angeles 33
Pune 33
Milan 30
Guangzhou 26
Philadelphia 22
Frankfurt Am Main 16
Helsinki 16
Vienna 16
Brussels 15
Tappahannock 15
Dearborn 14
Phoenix 14
Laurel 13
Council Bluffs 12
Redmond 11
San Mateo 11
Verona 11
Chicago 10
Kilburn 10
Bremen 8
Nanjing 8
Palermo 8
Prato 8
Seoul 8
Shenzhen 8
Bari 7
Cairo 7
Castelliri 7
Redwood City 7
Rome 7
Chiswick 6
Detroit 6
Leawood 6
Rui'an 6
Scarperia 6
Serra 6
São Paulo 6
Washington 6
A Coruña 5
Edmonton 5
Genoa 5
Munich 5
Old Bridge 5
Ottawa 5
Ponsacco 5
Sofia 5
Sydney 5
Trieste 5
Turin 5
Véry 5
Xian 5
Amman 4
Baku 4
Belo Horizonte 4
Bologna 4
Canicattì 4
Totale 27.807
Salva come PNG Salva come JPEG
Nome #
Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients 272
Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients 249
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 236
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 233
The intestinal microbiota in enthesitis-related arthitis 230
Managing pediatric osteoporosis 226
Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies 211
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 207
Anti-inflammatory and immunosuppressive drugs and reproduction. 186
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 186
Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa 184
Common symptoms for a rare disease in a girl with sarcoidosis: a case report 177
Distinctive features of classic and non-classic (Th17-derived) human Th1 cells. 171
Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). 170
Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. 168
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 162
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 158
Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease. 158
Musculin inhibits human T helper 17 cell response to interleukin 2 by controlling STAT5B activity 153
Kawasaki disease: an epidemiological study in central Italy 152
Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: The evidence from a systematic review and meta-analysis approach. 151
Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: Two case reports 151
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. 150
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 149
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up. 148
Kawasaki disease in Sicily: clinical description and markers of disease severity. 147
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. 146
Psoriatic juvenile idiopathic arthritis associated with uveitis: a case report. 145
T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies 143
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 143
Describing Kawasaki shock syndrome: results from a retrospective study and literature review 142
Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting 142
Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response 141
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. 141
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 141
Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options 140
Inflammatory morphea presenting as a hemifacial acquired port-wine stain 140
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 140
Demethylation of the RORC2 and IL17A in Human CD4+ T Lymphocytes Defines Th17 Origin of Nonclassic Th1 Cells. 139
Mycophenolate mofetil as induction and long-term maintaining treatment in childhood: Primary angiitis of the central nervous system 138
Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 138
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 137
Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone 134
Kawasaki disease in infants less than one year of age: An Italian cohort from a single center 128
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 127
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 127
Detection of anti-adalimumab antibodies in a RA responsive cohort of patients using three different techniques 126
Th17 and Th1 lymphocytes in oligoarticular juvenile idiopathic arthritis 126
Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach 125
Treating juvenile idiopathic arthritis to target: recommendations of an international task force 125
Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations. 124
Idiopathic congenital atrophoderma of Pasini and Pierini 123
Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. 121
Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation 121
Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA) 120
Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: Clinical and laboratory correlates of remission duration 119
A 10-year follow-up of alendronate-treated young patients 119
Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. 118
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome 117
Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. 116
Joint pain management in children and adolescents 115
Sex Differences in Pediatric Rheumatology 115
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: Our experience and review of the literature. 115
Glucocorticoids in the management of systemic juvenile idiopathic arthritis. 115
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 114
Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease. 113
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration 113
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 113
Sequential MR angiography in childhood primary angiitis of the CNS. 113
Biological treatments in behçet's disease: Beyond anti-TNF therapy 113
Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in italian children 112
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 112
Evidence of a Transient Nature of the th17 Phenotype of cd4+cd161+t Cells in the Synovial Fluid From Patients with Juvenile Idiopathic Arthritis 111
How advances in personalized medicine will change rheumatology 111
Childhood uveitis 111
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). 111
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 111
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 110
Pediatric Osteoporosis: Diagnosis and Treatment Considerations 110
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. 109
Anticorpi anti-istone: È sempre lupus indotto da farmaci? 109
Serum amyloid-A in Behçet's disease. 109
Clinical features and outcome of Cogan syndrome. 109
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 109
Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene. 108
Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis. 108
Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients. 108
Mucopolysaccharidoses. 107
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study. 107
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. 107
Recurrent Pericarditis In Children and Adolescents: Etiology, Presentation, Therapies, and Outcomes In a Multicenter Retrospective Cohort Of 100 Patients. 107
Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records 107
Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study. 107
Anti-TNF agents for the treatment of JIA-related Refractory Uveitis: 2010 UPDATE from the Italian Registry 107
How I treat juvenile idiopathic arthritis: A state of the art review 106
Cutaneous neonatal lupus: a case report and review of the literature. 105
Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis 105
Lupus, antiphospholipid syndrome and epilepsy: an update 105
Distal extremity pain as a presenting feature of Fabry's disease. 104
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis 104
Totale 13.642
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.416
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.294 0 0 0 0 0 0 0 708 672 392 411 111
2020/20213.300 322 271 242 324 143 351 125 242 332 410 250 288
2021/20223.007 115 333 234 160 87 129 92 254 151 89 327 1.036
2022/20237.742 955 1.820 258 524 539 1.439 846 351 587 33 257 133
2023/20242.103 101 342 515 132 129 323 63 287 42 59 69 41
2024/202512.034 727 1.837 1.097 2.369 4.172 1.356 246 230 0 0 0 0
Totale 39.641